Other revenues — Total revenues
Amgen Other revenues — Total revenues decreased by 95.4% to $400M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 95.1%, from $8.15B to $400M. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful monetization of secondary assets or growth in contract services, while a decrease may indicate a decline in royalty income or a strategic shift away from non-core operations.
Detailed definition
This metric represents the aggregate revenue generated from non-core or ancillary business activities that fall outside...
Peer comparison
Peers in the biotechnology and pharmaceutical sectors often report similar 'other' or 'miscellaneous' revenue categories, though the composition varies significantly based on the extent of contract manufacturing and licensing activities.
amgn_segment_other_revenues_total_revenuesHistorical Data
| Q2 '21 | Q2 '21 | Q3 '21 | Q3 '21 | Q4 '21 | Q4 '21 | Q1 '22 | Q1 '22 | Q2 '22 | Q2 '22 | Q3 '22 | Q3 '22 | Q4 '22 | Q4 '22 | Q1 '23 | Q1 '23 | Q2 '23 | Q2 '23 | Q3 '23 | Q3 '23 | Q4 '23 | Q4 '23 | Q1 '24 | Q1 '24 | Q2 '24 | Q2 '24 | Q3 '24 | Q3 '24 | Q4 '24 | Q4 '24 | Q1 '25 | Q1 '25 | Q2 '25 | Q2 '25 | Q3 '25 | Q3 '25 | Q4 '25 | Q4 '25 | Q1 '26 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.53B | $412M | $6.71B | $386M | $6.85B | $575M | $6.24B | $507M | $6.59B | $313M | $6.65B | $415M | $6.84B | $287M | $6.11B | $259M | $6.99B | $303M | $6.9B | $355M | $8.2B | $363M | $7.45B | $329M | $8.39B | $347M | $8.5B | $352M | $9.09B | $370M | $8.15B | $276M | $9.18B | $408M | $9.56B | $420M | $9.87B | $499M | $8.62B | $400M |
| QoQ Change | — | -93.7% | >999% | -94.2% | >999% | -91.6% | +984.9% | -91.9% | >999% | -95.3% | >999% | -93.8% | >999% | -95.8% | >999% | -95.8% | >999% | -95.7% | >999% | -94.9% | >999% | -95.6% | >999% | -95.6% | >999% | -95.9% | >999% | -95.9% | >999% | -95.9% | >999% | -96.6% | >999% | -95.6% | >999% | -95.6% | >999% | -94.9% | >999% | -95.4% |
| YoY Change | — | — | — | — | — | — | — | — | +1.0% | -95.2% | -0.8% | -93.8% | -0.1% | -95.8% | -2.1% | -95.8% | +5.9% | -95.4% | +3.8% | -94.7% | +19.8% | -94.7% | +22.0% | -94.6% | +20.1% | -95.0% | +23.2% | -94.9% | +10.9% | -95.5% | +9.4% | -96.3% | +9.4% | -95.1% | +12.4% | -95.1% | +8.6% | -94.5% | +5.8% | -95.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's other revenues — total revenues?
- Amgen (AMGN) reported other revenues — total revenues of $400M in Q1 2026.
- How has Amgen's other revenues — total revenues changed year-over-year?
- Amgen's other revenues — total revenues decreased by 95.1% year-over-year, from $8.15B to $400M.
- What does other revenues — total revenues mean?
- Total revenue generated from secondary business activities outside of the company's main therapeutic product lines.